Faes Farma revenue and financials
In the fiscal year ended December 2025, Faes Farma reported revenue of €626.99M (+22.93% year over year). Net income was €79.63M, a net margin of 12.7%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +22.93%
- 2025 vs 2024
- Net income growth
- −28.49%
- 2025 vs 2024
- Net margin
- 12.7%
- 2024: 21.8%
How Faes Farma is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 8.8% a year on average over the last 5 years
Compound annual growth rate: from €411.49M in 2020 to €626.99M in 2025.
Revenue has grown for 9 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin fell from 22.1% to 14.2%
Operating income over revenue, 2022 → 2025: 7.9 percentage points.
Less cash than profit: free cash flow equal to 53% of net income
Totals for fiscal years 2023–2025: free cash flow €149.25M, net income €282.89M.
Shares outstanding up 7.2% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 627 | 510 | 473 | 462 | 429 | 411 | 383 | 340 | 282 | 237 |
| Cost of revenue | 227 | 174 | 161 | 163 | 151 | 146 | 135 | 124 | 99.5 | 80.0 |
| Gross profit | 400 | 336 | 312 | 299 | 278 | 265 | 249 | 216 | 183 | 157 |
| Selling, general and administrative | 170 | 133 | 122 | 116 | 86.8 | 105 | 104 | 94.2 | 77.0 | 65.7 |
| Research and development | 4.9 | 5.8 | 5.2 | 3.7 | — | — | — | — | — | — |
| Operating income | 88.8 | 109 | 103 | 102 | 97.1 | 92.3 | 78.8 | 62.0 | 49.1 | 47.8 |
| EBIT | 88.8 | 109 | 103 | 102 | 97.1 | 92.3 | 78.8 | 62.0 | 49.1 | 47.8 |
| EBITDA | 112 | 125 | 119 | 118 | 111 | 104 | 89.2 | 71.9 | 57.2 | 53.3 |
| Interest expense | 4.6 | 0.4 | 0.4 | 0.3 | 0.2 | 0.3 | 0.1 | 0.3 | 0.2 | 0.0 |
| Pre-tax income | 85.4 | 108 | 103 | 101 | 93.0 | 84.9 | 74.2 | 61.7 | 49.5 | 46.1 |
| Income tax | 5.8 | -3.5 | 11.2 | 12.0 | 10.5 | 11.5 | 10.1 | 9.9 | 8.0 | 9.5 |
| Net income | 79.6 | 111 | 91.9 | 89.5 | 82.4 | 72.5 | 64.0 | 51.6 | 41.4 | 36.6 |
| Net income to common shareholders | 79.6 | 111 | 91.9 | 89.5 | 82.4 | 72.5 | 64.0 | 51.6 | 41.4 | 36.6 |
| Basic EPS | 0.26 | 0.36 | 0.30 | 0.29 | 0.28 | 0.26 | 0.23 | 0.19 | 0.16 | 0.15 |
| Diluted EPS | 0.25 | 0.36 | 0.30 | 0.29 | 0.27 | 0.25 | 0.23 | 0.19 | 0.16 | 0.15 |
| Average shares (basic) | 311 | 311 | 310 | 306 | 291 | 280 | 273 | 266 | 258 | 252 |
| Average shares (diluted) | 313 | 312 | 311 | 306 | 305 | 292 | 273 | 266 | 258 | 252 |
| Dividend per share | 0.13 | 0.18 | 0.16 | 0.16 | 0.21 | 0.20 | 0.17 | 0.14 | 0.02 | 0.02 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 172 | 191 | 200 | 173 | 147 | 154 | 153 | 117 | 119 | 135 | 139 | 111 |
| Cost of revenue | 61.1 | 60.2 | 61.6 | 73.4 | 52.4 | 52.6 | 48.6 | 51.4 | 39.4 | 41.4 | 41.9 | 47.2 |
| Gross profit | 111 | 131 | 138 | 99.5 | 94.2 | 102 | 104 | 65.8 | 79.9 | 93.3 | 97.1 | 63.9 |
| Selling, general and administrative | 36.6 | 44.1 | 45.7 | 80.8 | 27.4 | 31.3 | 30.8 | 51.5 | 25.5 | 27.7 | 27.8 | 49.5 |
| Operating income | 23.5 | 32.6 | 38.4 | 1.1 | 26.1 | 28.1 | 33.5 | 14.2 | 25.9 | 32.5 | 35.9 | 15.4 |
| EBIT | 23.5 | 32.6 | 38.4 | 1.1 | 26.1 | 28.1 | 33.5 | 14.2 | 25.9 | 32.5 | 35.9 | 15.4 |
| EBITDA | 29.4 | 40.5 | 44.2 | 6.9 | 30.1 | 33.9 | 37.5 | 18.2 | 29.9 | 37.5 | 39.8 | 19.4 |
| Interest expense | 3.0 | 3.6 | 2.0 | 3.5 | 2.0 | 197 | — | 0.1 | 0.7 | — | — | 0.2 |
| Pre-tax income | 20.5 | 30.5 | 36.4 | -1.4 | 25.2 | 27.8 | 33.9 | 13.1 | 25.6 | 32.9 | 36.0 | 15.3 |
| Income tax | 3.2 | 4.3 | 5.5 | -7.4 | 3.8 | 3.9 | 5.5 | -18.3 | 4.1 | 5.0 | 5.6 | -2.4 |
| Net income | 17.2 | 26.1 | 30.8 | 6.1 | 21.2 | 24.0 | 28.4 | 31.5 | 21.5 | 27.9 | 30.5 | 17.7 |
| Net income to common shareholders | 17.2 | 26.1 | 30.8 | 6.1 | 21.2 | 24.0 | 28.4 | 31.5 | 21.5 | 27.9 | 30.5 | 17.7 |
| Basic EPS | 0.06 | 0.08 | — | 0.02 | — | 0.08 | — | 0.10 | — | 0.09 | — | 0.06 |
| Diluted EPS | 0.05 | 0.08 | — | 0.02 | — | 0.08 | — | 0.10 | — | 0.09 | — | 0.06 |
| Average shares (basic) | 311 | 311 | — | 311 | — | 311 | — | 311 | — | 311 | — | 311 |
| Average shares (diluted) | 311 | 311 | — | 311 | — | 311 | — | 311 | — | 311 | — | 311 |
| Dividend per share | — | — | — | 0.09 | 0.00 | 0.04 | — | 0.14 | 0.00 | 0.04 | — | 0.12 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1,342 | 853 | 777 | 727 | 645 | 582 | 494 | 471 | 430 | 331 |
| Current assets | 482 | 334 | 290 | 313 | 294 | 290 | 223 | 218 | 170 | 154 |
| Cash and equivalents | 117 | 64.2 | 34.6 | 66.4 | 70.3 | 91.2 | 52.9 | 76.0 | 43.3 | 58.8 |
| Short-term investments | 12.8 | 7.9 | 13.1 | 17.7 | 0.9 | — | — | — | — | — |
| Receivables | 167 | 118 | 113 | 114 | 112 | 105 | 96.8 | 81.5 | 76.3 | 49.1 |
| Inventory | 185 | 143 | 129 | 115 | 107 | 91.6 | 71.5 | 59.3 | 49.9 | 38.3 |
| Net property, plant and equipment | 352 | 300 | 103 | 108 | 118 | 88.1 | 81.5 | 61.9 | 58.2 | 28.1 |
| Goodwill | 258 | 56.5 | 56.4 | 51.8 | 53.3 | 52.6 | 54.8 | 53.9 | 53.2 | 17.3 |
| Other intangible assets | 178 | 119 | 116 | 104 | 109 | 97.0 | 103 | 102 | 107 | 66.3 |
| Long-term investments | 1.5 | 0.2 | 0.3 | 5.1 | 1.0 | 0.3 | 0.5 | — | — | — |
| Current liabilities | 185 | 103 | 87.3 | 94.4 | 79.3 | 84.7 | 72.3 | 104 | 56.5 | 37.9 |
| Accounts payable | 83.4 | 46.8 | 35.4 | 36.6 | 37.9 | 42.0 | 37.7 | 35.6 | 31.0 | 19.0 |
| Long-term debt | 376 | 2.6 | 3.5 | 3.8 | 3.5 | 3.5 | 3.6 | 4.1 | 44.4 | 1.2 |
| Total debt | 421 | 13.5 | 16.4 | 25.7 | 13.9 | 13.0 | 14.2 | 52.2 | 49.9 | 1.9 |
| Total liabilities | 596 | 126 | 113 | 125 | 108 | 109 | 80.0 | 111 | 109 | 46.3 |
| Total equity (incl. minority) | 746 | 727 | 663 | 602 | 537 | 473 | 414 | 360 | 320 | 285 |
| Retained earnings | 729 | 704 | 641 | 577 | 510 | 446 | 386 | 333 | 291 | 256 |
| Minority interest | 0.8 | 0.7 | 1.0 | 1.2 | 1.5 | 1.5 | 0.7 | 0.3 | 0.5 | 0.0 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 1,442 | — | 1,342 | — | 1,000 | — | 853 | — | 838 | — | 777 |
| Current assets | — | 524 | — | 482 | — | 423 | — | 334 | — | 347 | — | 290 |
| Cash and equivalents | — | 124 | — | 117 | — | 103 | — | 64.2 | — | 60.7 | — | 34.6 |
| Short-term investments | — | 13.1 | — | 12.8 | — | 8.3 | — | 7.9 | — | 9.1 | — | 13.1 |
| Receivables | — | 194 | — | 167 | — | 156 | — | 118 | — | 138 | — | 113 |
| Inventory | — | 193 | — | 185 | — | 155 | — | 143 | — | 139 | — | 129 |
| Net property, plant and equipment | — | 344 | — | 352 | — | 317 | — | 300 | — | 98.9 | — | 103 |
| Goodwill | — | 151 | — | 258 | — | 103 | — | 56.5 | — | 56.4 | — | 56.4 |
| Other intangible assets | — | 361 | — | 178 | — | 116 | — | 119 | — | 114 | — | 116 |
| Long-term investments | — | 1.6 | — | 1.5 | — | 0.7 | — | 0.2 | — | 0.2 | — | 0.3 |
| Current liabilities | — | 199 | — | 185 | — | 184 | — | 103 | — | 127 | — | 87.3 |
| Accounts payable | — | 122 | — | 83.4 | — | 92.4 | — | 46.8 | — | 25.8 | — | 35.4 |
| Long-term debt | — | 380 | — | 376 | — | 65.9 | — | 2.6 | — | 3.1 | — | 3.5 |
| Total debt | — | 422 | — | 421 | — | 104 | — | 13.5 | — | 11.3 | — | — |
| Total liabilities | — | 667 | — | 596 | — | 270 | — | 126 | — | 152 | — | 113 |
| Total equity (incl. minority) | 775 | 775 | 746 | 746 | 730 | 730 | 727 | 727 | 686 | 686 | 663 | 663 |
| Retained earnings | — | 196 | — | 729 | — | 167 | — | 704 | — | 156 | — | 641 |
| Minority interest | — | 0.9 | — | 0.8 | — | 0.6 | — | 0.7 | — | 0.9 | — | 1.0 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 78.5 | 115 | 101 | 107 | 79.6 | 78.5 | 67.6 | 59.3 | 41.7 | 49.6 |
| Depreciation and amortization | 27.8 | 19.3 | 18.4 | 18.5 | 16.5 | 14.3 | 12.2 | 9.9 | 8.2 | 5.4 |
| Capital expenditure | -16.1 | -33.8 | -95.8 | -75.2 | -51.5 | -20.2 | -17.0 | -12.7 | -12.1 | -10.8 |
| Investing cash flow | -299 | -34.2 | -97.4 | -92.4 | -83.5 | -25.8 | -34.0 | -19.6 | -83.2 | -11.5 |
| Financing cash flow | 274 | -51.7 | -35.4 | -18.5 | -17.1 | -14.4 | -56.7 | -7.0 | 25.9 | -4.8 |
| Dividends paid | -55.7 | -48.2 | -14.6 | -18.1 | -4.9 | -4.2 | -4.3 | -7.5 | -6.3 | -5.3 |
| Share repurchases | — | 0.0 | -17.7 | 0.0 | 0.0 | -0.1 | -2.8 | -1.6 | -0.5 | -0.2 |
| Debt issued | 375 | 0.0 | 0.3 | 2.3 | — | — | 0.4 | 3.2 | 40.9 | 0.7 |
| Debt repaid | -46.9 | -3.5 | -3.3 | -2.6 | -3.4 | -2.7 | -43.9 | -1.1 | -8.3 | — |
| Net change in cash | 53.1 | 29.6 | -31.8 | -3.8 | -21.0 | 38.4 | -23.2 | 32.8 | -15.6 | 33.3 |
| Free cash flow | 62.4 | 81.7 | 5.2 | 31.8 | 28.2 | — | — | — | — | — |
| Levered free cash flow | 18.0 | 46.2 | -30.1 | -4.8 | -13.3 | 30.2 | 21.8 | 17.2 | -3.4 | 21.0 |
Financial statements of similar companies
Companies in the group: same industry, similar size
